Edition:
India

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

2.95USD
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
$2.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,256
52-wk High
$9.90
52-wk Low
$2.15

Select another date:

Mon, Jan 8 2018

BRIEF-Xenon Pharmaceuticals Expects To Have Ongoing XEN1101 Phase 1 Clinical Trial Completed By Mid-Year

* XENON PHARMACEUTICALS INC - EXPECT TO HAVE ONGOING XEN1101 PHASE 1 CLINICAL TRIAL COMPLETED BY MID-YEAR

BRIEF-Xenon Pharma Says Entered Into Loan And Security Agreement With Silicon Valley Bank

* XENON PHARMACEUTICALS- ON DEC 18, CO, UNIT ENTERED INTO LOAN AND SECURITY AGREEMENT WITH SILICON VALLEY BANK - SEC FILING

BRIEF-Xenon Pharmaceuticals reports Q3 loss per share $0.43

* Xenon Pharmaceuticals reports third quarter 2017 financial results and provides corporate update

BRIEF-Xenon Pharma announces initiation of XEN1101 phase 1 clinical trial

* Xenon Pharmaceuticals announces initiation of XEN1101 phase 1 clinical trial

BRIEF-Xenon Pharmaceuticals Q2 net loss per common share $0.41​

* Xenon Pharmaceuticals reports second quarter 2017 financial results and provides corporate update

Select another date: